BioCentury
ARTICLE | Company News

Protagen, Werfen deal

August 22, 2016 7:00 AM UTC

Protagen granted Werfen’s Inova Diagnostics Inc. company semi-exclusive rights to develop and commercialize biomarker bicaudal D homolog 2 (BICD2), which Inova will add to its assay portfolio. The co...